Allergan Successfully Invalidates Claims Relating to Using Botox to Treat Back Pain

Allergan Successfully Invalidates Claims Relating to Using Botox to Treat Back Pain


Allergan is typically the patent holder in these types of disputes, however, it recently successfully played the role of petitioner in an IPR against 1474791 Ontario Ltd.'s U.S. Patent No. 6,806,251 covering the use of botulinum toxin to treat spinal compression.



from Biotech News